Melt Pharmaceuticals raises $24 million for drug development
Melt Pharmaceuticals, a spin-off of Harrow Inc., is looking to change the game in pain management for medical procedures. Here's how it's using $24 million in funding to do that and what's next for its drug development. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 3, 2024 Category: Biotechnology Authors: Nikki Ross Source Type: news
Kaiser ’s new D.C. health nonprofit just closed its first acquisition. Here’s what’s on deck.
The deal also gives the local entity a CEO. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 3, 2024 Category: Biotechnology Authors: Sara Gilgore Source Type: news
Billion-dollar firm moves to buy RTP outfit in need of capital
A public company in Research Triangle Park has a deal to be acquired by a German firm in order to advance its robotic surgical device. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 3, 2024 Category: Biotechnology Authors: Zac Ezzone Source Type: news
AHWFB opens urgent care clinic near site of proposed $246M Greensboro hospital
Winston-Salem's AHWFB has opened another location in Greensboro. Here's why this urgent care clinic, less than four miles away from a controversial site, matters. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 3, 2024 Category: Biotechnology Authors: Lillian Johnson Source Type: news
Polio vaccine shortage looms over India with Sanofi plants' shutdown
An impending crisis looms over India's supply of injectable poliomyelitis vaccine (IPV) as French drugmaker Sanofi has shut down its manufacturing plants in the country, halting production of its IPV brand ShanIPV in December 2023. Sanofi's closure has raised concerns about disruptions in India's polio eradication efforts, as it catered to over 80% of the country's IPV dose requirements. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 3, 2024 Category: Pharmaceuticals Source Type: news
Atrium Health CEO Gene Woods on goals, honor of receiving Charlotte Center City Partners' 2024 Vision Award
Atrium Health President and CEO Gene Woods is being honored by Charlotte Center City Partners for his contributions to the city. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 3, 2024 Category: Biotechnology Authors: Elise Franco Source Type: news
Digital database of organ donors on cards for smooth transplants
The register will serve as a single platform with Aadhaar authenticated data for all donors and patients waiting for organ transplant to ensure in-time and transparent organ donation in the country while doing away with the middlemen. India has 0.14 million potential donors who have voluntarily pledged their organs and the government aims to have 10 million prospective donors by the end of 2024 under the Angdaan Mahotsav, which started in July 2023. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 3, 2024 Category: Pharmaceuticals Source Type: news
BayCare plans $548 million hospital in Manatee County
The Clearwater-based health system said the Manatee facility will be its 17th hospital. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 3, 2024 Category: Biotechnology Authors: Ashley Gurbal Kritzer Source Type: news
Miami-Dade rehab facility plans major expansion (Photos)
The revamped location would house 120 residents. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 3, 2024 Category: Biotechnology Authors: Brian Bandell Source Type: news
Adaptive Biotechnologies Names New CFO Preserves Strong Capital Position
Adaptive Biotechnologies Corporation ADPT announced Tuesday, April 3, that after a strategic review, the company will operate two businesses — Minimal Residual Disease (MRD) and Immune Medicine (IM) — internally. The company will also restructure each business with dedicated resources and separate…#mrd #immunemedicine #adaptive #tychopeterson #cfo #kylepiskel #williamblair #adpt (Source: Reuters: Health)
Source: Reuters: Health - April 3, 2024 Category: Consumer Health News Source Type: news
D.C. biotech scores FDA approval for key drug, stock surges
The agency ’s nod “significantly increases the commercial opportunity” for the treatment of bipolar disorder, the company said. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 3, 2024 Category: Pharmaceuticals Authors: Sara Gilgore Source Type: news
Lupin appoints Dr Ranjana Pathak as chief quality officer
Dr. Ranjana Pathak appointed Lupin's chief quality officer, succeeding Johnny Mikell. With 30 years of experience, she led quality at Cipla, Watson/Actavis, and Endo Pharmaceuticals. Lupin invests in R&D. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 3, 2024 Category: Pharmaceuticals Source Type: news
New Paragon spinout lands $275M financing — and reverse merger
The third spinout from Paragon Therapeutics launched on Wednesday with a new private financing — and, in an unusual move, a plan to go public within a few months. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 3, 2024 Category: Biotechnology Authors: Hannah Green Source Type: news
Atlas-backed Diagonal Therapeutics launches with $128M
The Cambridge biotech is working on new ways to discover and develop “agonist antibodies,” and its Series A round was co-led by Atlas Venture and BVF Partners. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 3, 2024 Category: Biotechnology Authors: Hannah Green Source Type: news
EnteroBiotix Initiates Phase 2 Study of EBX-102-02 in Patients with Irritable Bowel Syndrome (IBS)
GLASGOW, Scotland, April 03, 2024 (GLOBE NEWSWIRE) -- EnteroBiotix Limited, a clinical-stage biotechnology company focussed on developing best-in-class full-spectrum microbiome therapeutics, today announced that the first patient has been dosed in a multi-centre randomised double-blind placebo…#glasgow #scotland #enterobiotixlimited #ibs #unitedkingdom #functionalgutclinic #amplatm #gmp #jamesmcilroy #enterobiotix (Source: Reuters: Health)
Source: Reuters: Health - April 3, 2024 Category: Consumer Health News Source Type: news
